AKR1C2 and lung cancer: Taken together, we suggest that AKR1C2 may promote LUAD by inhibiting ferroptosis, and AKR1C2 knockdown helps to promote ferroptosis in lung cancer cells, thereby inhibiting lung cancer progression.